Simon Hirst
Simon Hirst is the Founder and Chief Executive Officer of Sygnature Discovery.
He is a medicinal chemist with 21 years experience in the pharmaceutical industry. Simon has been engaged in the full spectrum of drug discovery programmes - from lead generation libraries, hit-to-lead campaigns, all the way to successful lead optimisation projects and candidate drug selection.
Simon has broad-ranging experience of research in a large pharmaceutical company (AstraZeneca), a mid-size biotech (OSI Pharmaceuticals); as well as in a more commercial environment at CombiPure Ltd., where he was Managing Director and Director of Chemistry.
He has a BSc (Hons.) in chemistry, and a PhD in synthetic organic chemistry from the University of Nottingham, and undertook post-doctoral research at the University of Pittsburgh.